Women's Health

Light Search completed

Invite

Radar Tracking

Subspaces (5)

Wearable Health Devices

Mobile Health Applications

Artificial Intelligence in Women's Health Care

Genomic and Genetic Testing

Health Information Systems

Pending to review

Not sure yet

Interested

Not interested

Download list

Showing 60 results

Company	Fit assessment	Description	Subspaces	Tags	HQ Location	Founding Date	Employees	Total Funding Raised	Last Funding Event	Received on
Philips	Philips is a global healthcare company focused on enhancing health and well-being through innovative technologies. Their offerings include advanced imaging systems, ultrasound equipment, and connected care solutions that support patient diagnosis and treatment.	Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.	Wearable Health Devices Mobile Health Applications	Light Search	Amsterdam (Netherlands)	1891	+10000		Acquired by Philips, November 2017	Oct 15, 2024
Roche Diagnostics	Roche is a leading biopharmaceutical and diagnostic company that develops innovative drugs and diagnostic solutions, particularly in oncology and personalized healthcare. They are also committed to addressing healthcare inequities and improving access to medical innovations for women.	Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com/global/en Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation	Genomic and Genetic Testing	Light Search	Basel (Switzerland)		98227	$2.79B	Post-IPO Equity, $2.79B, May 8, 2001	Oct 15, 2024
GE Healthcare	GE Healthcare is a prominent medical technology firm specializing in imaging and ultrasound equipment, as well as data analytics and digital solutions. Their offerings include advanced devices and applications aimed at enhancing healthcare outcomes and operational efficiency.	GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).	Health Information Systems	Light Search	Chicago (United States)	1892	+10000	$5.52B	Venture - Series Unknown, $1.17B, November 7, 2024	Oct 15, 2024
Johnson & Johnson	Johnson & Johnson is a leading healthcare company that develops and sells a wide range of medical devices and pharmaceuticals. Their focus includes innovative solutions aimed at addressing various health challenges across multiple therapeutic areas.	Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.	Mobile Health Applications	Light Search	New Brunswick (United States)	1886	+10000		IPO, September 24, 1944	Oct 15, 2024
Ovia Health	Ovia Health provides a digital platform with mobile applications focused on fertility, pregnancy, and parenting, supporting women and families throughout their journey. The company aims to enhance health outcomes and empower users to make informed decisions regarding their reproductive health.	Developer of a digital healthcare platform designed to provide customized information regarding maternity benefits for women and their families. The company's platform offers a suite of mobile applications for fertility, pregnancy and parenting, thereby enabling women to take control of their health and start a family with confidence.	Mobile Health Applications Artificial Intelligence in Women's Health Care	Light Search	United States	2011	51 - 200	$23.30M	Acquired by LabCorp, August 2021	Oct 15, 2024
kahla	Kahla develops a comprehensive mobile health application that enhances research, diagnosis, treatment, and care for women's health.	The AI-powered hormone health app for women. Now available for iOS: http://apple.co/45WoArI	Mobile Health Applications	Light Search	United States	2022	1 - 10		NA	Oct 15, 2024
SH Safrn Health	Safrn Health empowers physicians to improve care for women through its AI-driven platform, enhancing the effectiveness of healthcare delivery.	Developer of an AI-based healthcare platform designed to tackle the costly, chronic condition burden faced by women starting with endocrine disorders. The company's platform reduces the risk of chronic conditions in women, and more, thereby empowering physicians to deliver tailored, and effective care.	Artificial Intelligence in Women's Health Care	Light Search	Boston (United States)	2022	1 - 10		NA	Oct 15, 2024
Grace.Health	Grace Health is a digital platform focused on women's health in emerging markets, providing services like cycle tracking, fertility predictions, and access to affordable healthcare. The app aims to empower women with low health literacy by offering personalized health information and support.	Operator of a digital health platform intended to track menstruation and ovulation for female health. The company's platform has an automated health assistant that is integrated with messaging services for smartphones, acting as a chatbot that provides fertility tracking and cycle prediction services, enabling women in emerging markets to have information about menstruation, health and affordable health services using their mobile phones.	Artificial Intelligence in Women's Health Care Health Information Systems	Light Search	Sweden	2017	27	$5.10M	Acquired by Penda Health, November 2023	Oct 15, 2024
Illumigyn	Illumigyn develops a compact imaging device that enhances cervical examinations by providing high-resolution images and multispectral illumination. Their technology aims to improve diagnostic accuracy and reduce misdiagnoses in gynecological care.	Developer of a compact imaging colposcope designed to eliminate the subjectivity of cervical cancer exams. The company's colposcope is based on a medical application that delivers down to micron image resolution and has multispectral illumination options to reduce the subjectivity of machine vision technologies, enabling doctors with sophisticated imaging along with simultaneous complex interventional procedures to assist the best clinical outcomes.	Health Information Systems Artificial Intelligence in Women's Health Care	Light Search	Israel	2012	26	$33.00M	Venture - Series Unknown, $33.00M, November 3, 2021	Oct 15, 2024
Maven	Maven Clinic is a digital healthcare platform that provides on-demand support for families during conception, pregnancy, and postpartum. It offers a network of health practitioners and services for various family health needs, including fertility and reproductive care.	Developer of a digital health platform designed to improve care for women and families, delivering improved outcomes and low costs for everyone. The company's services aid in booking appointments through a network of nurses, gynecologists, mental health specialists, physical therapists, and nutritionists and offers dedicated care and data-driven insights, enabling individuals to avail of hassle-free healthcare services.	Artificial Intelligence in Women's Health Care	Light Search	United States	2014	201 - 500	$417.10M	Series F+, $125.00M, October 8, 2024	Oct 15, 2024